The pharmaceutical company Boehringer Ingelheim has announced a significant investment of £150 million to establish an artificial intelligence and machine learning centre in London’s Knowledge Quarter. This marks the first
The pharmaceutical company Boehringer Ingelheim has announced a significant investment of £150 million to establish an artificial intelligence and machine learning centre in London’s Knowledge Quarter. This marks the first






